Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
FMC Stock Forecast 2026-2027
$17.17
Current Price
$2.15B
Market Cap
Buy 5
Hold 12
Sell 1
Wall St Analyst Ratings
Distance to FMC Price Targets
+51.4%
To High Target of $26.00
-9.7%
To Median Target of $15.50
-24.3%
To Low Target of $13.00
FMC Price Momentum
-5.0%
1 Week Change
+31.2%
1 Month Change
-54.6%
1 Year Change
+23.8%
Year-to-Date Change
-61.7%
From 52W High of $44.78
+41.1%
From 52W Low of $12.17
📊 TOP ANALYST CALLS
Did FMC Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if FMC Corp is one of their latest high-conviction picks.
Latest FMC Stock Price Targets & Analyst Predictions
Based on our analysis of 31 Wall Street analysts, FMC has a neutral consensus with a median price target of $15.50 (ranging from $13.00 to $26.00). The overall analyst rating is Buy (6.9/10). Currently trading at $17.17, the median forecast implies a -9.7% downside. This outlook is supported by 5 Buy, 12 Hold, and 1 Sell ratings.
Conversely, the most conservative target is provided by Benjamin Theurer at Barclays, suggesting a 24.3% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
FMC Analyst Ratings
5
Buy
12
Hold
1
Sell
FMC Price Target Range
Low
$13.00
Average
$15.50
High
$26.00
Current: $17.17
Latest FMC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for FMC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 14, 2026 | Goldman Sachs | Duffy Fischer | Buy | Maintains | $21.00 |
| Apr 9, 2026 | UBS | Joshua Spector | Neutral | Maintains | $17.00 |
| Feb 17, 2026 | Mizuho | Edlain Rodriguez | Outperform | Maintains | $20.00 |
| Feb 9, 2026 | Citigroup | Patrick Cunningham | Neutral | Maintains | $14.00 |
| Feb 6, 2026 | Wells Fargo | Michael Sison | Equal-Weight | Maintains | $14.00 |
| Feb 6, 2026 | RBC Capital | Arun Viswanathan | Sector Perform | Maintains | $14.00 |
| Jan 21, 2026 | Citigroup | Patrick Cunningham | Neutral | Maintains | $16.00 |
| Jan 16, 2026 | Mizuho | Edlain Rodriguez | Outperform | Maintains | $21.00 |
| Jan 12, 2026 | UBS | Joshua Spector | Neutral | Maintains | $15.00 |
| Dec 18, 2025 | Citigroup | Patrick Cunningham | Neutral | Maintains | $14.00 |
| Dec 15, 2025 | Mizuho | Christopher Parkinson | Outperform | Maintains | $24.00 |
| Dec 9, 2025 | Barclays | Benjamin Theurer | Underweight | Downgrade | $13.00 |
| Nov 17, 2025 | JP Morgan | Jeffrey Zekauskas | Neutral | Maintains | $14.00 |
| Nov 13, 2025 | Barclays | Benjamin Theurer | Equal-Weight | Maintains | $16.00 |
| Nov 3, 2025 | Morgan Stanley | Vincent Andrews | Equal-Weight | Maintains | $17.00 |
| Nov 3, 2025 | Goldman Sachs | Duffy Fischer | Buy | Maintains | $19.00 |
| Oct 31, 2025 | Keybanc | Aleksey Yefremov | Sector Weight | Downgrade | $N/A |
| Oct 31, 2025 | Wells Fargo | Richard Garchitorena | Equal-Weight | Downgrade | $16.00 |
| Oct 31, 2025 | RBC Capital | Arun Viswanathan | Sector Perform | Maintains | $17.00 |
| Oct 31, 2025 | UBS | Joshua Spector | Neutral | Maintains | $17.00 |
FMC Corporation (FMC) Competitors
The following stocks are similar to FMC Corp based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
FMC Corporation (FMC) Financial Data
FMC Corporation has a market capitalization of $2.15B with a P/E ratio of 29.4x. The company generates $3.47B in trailing twelve-month revenue with a -64.6% profit margin.
Revenue growth is -11.5% quarter-over-quarter, while maintaining an operating margin of +9.5% and return on equity of -66.6%.
Valuation Metrics
Market Cap
$2.15B
Enterprise Value
$5.79B
P/E Ratio
29.4x
PEG Ratio
0.0x
Price/Sales
0.6x
Growth & Margins
Revenue Growth (YoY)
-11.5%
Gross Margin
+39.8%
Operating Margin
+9.5%
Net Margin
-64.6%
EPS Growth
-11.5%
Financial Health
Cash/Price Ratio
+27.2%
Current Ratio
1.3x
Debt/Equity
200.0x
ROE
-66.6%
ROA
+1.4%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
FMC Corporation (FMC) Business Model
About FMC Corporation
What They Do
Develops crop protection solutions for farmers.
Business Model
The company generates revenue by providing a wide range of agricultural products including insecticides, herbicides, fungicides, and bionematicides. FMC Corporation serves both crop and non-crop segments, ensuring diverse income streams through advanced farming technologies and solutions that enhance crop productivity and resilience.
Additional Information
FMC Corporation operates globally in over 50 countries and has a strong commitment to sustainable agriculture. Founded in 1883 and headquartered in Philadelphia, it leverages its innovative portfolio to address pest control, plant health, and turf management needs.
Company Information
Sector
Basic Materials
Industry
Agricultural Inputs
Employees
5,500
CEO
Dr. Pierre R. Brondeau Ph.D.
Country
United States
IPO Year
1985
Website
www.fmc.comFMC Corporation (FMC) Latest News & Analysis
Latest News
Quick Summary
Old North State sold its 295,829 FMC shares in Q1 for approximately $4.42 million. The quarter-end position value fell by $4.10 million due to trading and share price changes.
Why It Matters
Old North State's divestment from FMC signals a potential lack of confidence in the company's future performance, impacting market perception and possibly influencing stock prices.
Source: The Motley Fool
Market Sentiment:
Negative
Quick Summary
FMC announced in February that it is exploring strategic options due to declining revenue.
Why It Matters
FMC's pursuit of strategic options amid declining revenue signals potential restructuring or sale, which could impact stock performance and investor sentiment.
Source: The Motley Fool
Market Sentiment:
Neutral
Why FMC Rallied in March, Even As Markets Fell
11 days ago
Quick Summary
FMC's CEO reported interest from 5 to 10 potential buyers for the company. Additionally, the war in Iran is affecting supply in the agricultural chemicals sector.
Why It Matters
FMC's potential sale interest indicates strong market value, while supply constraints from the Iran conflict could drive prices higher, impacting profitability and market dynamics in agriculture.
Source: The Motley Fool
Market Sentiment:
Negative
Quick Summary
FMC receives EU approval for Isoflex herbicide, opening access to over 55 million hectares in a market with few new crop protection options.
Why It Matters
FMC's EU approval for Isoflex expands its market potential significantly, addressing unmet demand in crop protection, which could enhance revenue and market share.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Up to 10 parties may be interested in acquiring FMC, but a deal is not guaranteed.
Why It Matters
The interest from multiple parties in acquiring FMC suggests potential for a bidding war, which could drive up the company's stock price and enhance shareholder value.
Source: The Motley Fool
Market Sentiment:
Negative
Quick Summary
FMC Corporation's Isoflex® (bixlozone) has received EU regulatory approval, enabling commercialization for use on over 55 million hectares of cereals, corn, oilseed rape, and potatoes.
Why It Matters
FMC's regulatory approval for Isoflex® in the EU expands its market access, potentially increasing revenue from a large agricultural sector, which can positively impact stock performance.
Source: PRNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About FMC Stock
What is FMC Corporation's (FMC) stock forecast for 2026?
Based on our analysis of 31 Wall Street analysts, FMC Corporation (FMC) has a median price target of $15.50. The highest price target is $26.00 and the lowest is $13.00.
Is FMC stock a good investment in 2026?
According to current analyst ratings, FMC has 5 Buy ratings, 12 Hold ratings, and 1 Sell ratings. The stock is currently trading at $17.17. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for FMC stock?
Wall Street analysts predict FMC stock could reach $15.50 in the next 12 months. This represents a -9.7% decrease from the current price of $17.17. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is FMC Corporation's business model?
The company generates revenue by providing a wide range of agricultural products including insecticides, herbicides, fungicides, and bionematicides. FMC Corporation serves both crop and non-crop segments, ensuring diverse income streams through advanced farming technologies and solutions that enhance crop productivity and resilience.
What is the highest forecasted price for FMC FMC Corporation?
The highest price target for FMC is $26.00 from at , which represents a 51.4% increase from the current price of $17.17.
What is the lowest forecasted price for FMC FMC Corporation?
The lowest price target for FMC is $13.00 from Benjamin Theurer at Barclays, which represents a -24.3% decrease from the current price of $17.17.
What is the overall FMC consensus from analysts for FMC Corporation?
The overall analyst consensus for FMC is neutral. Out of 31 Wall Street analysts, 5 rate it as Buy, 12 as Hold, and 1 as Sell, with a median price target of $15.50.
How accurate are FMC stock price projections?
Stock price projections, including those for FMC Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 19, 2026 4:27 PM UTC